Skip to main content
Top
Published in: Neurological Sciences 5/2013

01-05-2013 | Original Article

Retinal nerve changes in patients with tremor dominant and akinetic rigid Parkinson’s disease

Authors: Mohammad Rohani, Arash Sefidkar Langroodi, Shadi Ghourchian, Khalil Ghasemi Falavarjani, Reza SoUdi, Gholamali Shahidi

Published in: Neurological Sciences | Issue 5/2013

Login to get access

Abstract

Parkinson disease is a multisystem neurodegenerative disease which involves not only basal ganglia and extrapyramidal system but also many other neurologic systems such as retinal ganglion cells. Optical coherence tomography (OCT) is a non-invasive method for assessment of retinal nerve fiber layer (RNFL) thickness and its changes in different diseases. To evaluate the RNFL thickness in patients with Parkinson disease (PD), we performed OCT in patients with PD and compared it with a control group. From October 2010 to July 2011, 27 PD patients (54 eyes) and 25 healthy persons (50 eyes) were entered to this analytical cross-sectional study according to the defined criteria. PD patients were categorized into two groups “akinetic rigid (AR) and tremor dominant (TD)”. RNFL was divided into four quadrants and was assessed by OCT. Afterwards; the data were analyzed by bivariate and multivariate models. The RNFL thickness in PD was significantly lower than the control group. Also, the thicknesses of inferior and nasal quadrants of RNFL in TD group were significantly more than AR group. According to these findings, OCT can be used as a sensitive and objective marker for assessment of early neurodegenerative changes of PD and early initiation of neuroprotective treatments. Future studies with adequate sample sizes are recommended to investigate interactions between age, distribution of the disease and type of PD as well as the effects of individual factors.
Literature
1.
go back to reference Djamgoz MB, Hankins MW, Hirano J, Archer SN (1997) Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res 37:3509–3529PubMedCrossRef Djamgoz MB, Hankins MW, Hirano J, Archer SN (1997) Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res 37:3509–3529PubMedCrossRef
2.
go back to reference Korell M, Tanner C (2005) Epidemiology of Parkinson’s disease. In: Ebadi M, Pfeiffer R (eds) Parkinson’s disease. CRC Press, New York, pp 39–50 Korell M, Tanner C (2005) Epidemiology of Parkinson’s disease. In: Ebadi M, Pfeiffer R (eds) Parkinson’s disease. CRC Press, New York, pp 39–50
3.
go back to reference Braak H, Del Tredici K, Bratzke H et al (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol 249:1–5CrossRef Braak H, Del Tredici K, Bratzke H et al (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol 249:1–5CrossRef
4.
5.
go back to reference Diederich NJ, Raman R, Leurgans S, Goetz CG (2002) Progressive worsening of spatial and chromatic processing deficits in Parkinson’s disease. Arch Neurol 59:1249–1252PubMedCrossRef Diederich NJ, Raman R, Leurgans S, Goetz CG (2002) Progressive worsening of spatial and chromatic processing deficits in Parkinson’s disease. Arch Neurol 59:1249–1252PubMedCrossRef
6.
go back to reference Hajee ME et al (2009) Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 127(6):737–741PubMedCrossRef Hajee ME et al (2009) Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 127(6):737–741PubMedCrossRef
7.
go back to reference Altintas O (2008) Correlation between retinal morphological and functional findings and clinical severity in Parkinson’s disease. Doc Ophthalmol 116:137–146PubMedCrossRef Altintas O (2008) Correlation between retinal morphological and functional findings and clinical severity in Parkinson’s disease. Doc Ophthalmol 116:137–146PubMedCrossRef
8.
9.
go back to reference Inzelberg R, Ramirez JA, Niisipeanu P, Ophir A (2004) Retinal nerve fiber layer thinning in Parkinson disease. Vis Res 44:2793–2797PubMedCrossRef Inzelberg R, Ramirez JA, Niisipeanu P, Ophir A (2004) Retinal nerve fiber layer thinning in Parkinson disease. Vis Res 44:2793–2797PubMedCrossRef
10.
go back to reference Parisi V, Manni G, Sparado M, Colacino G, Restuccia R, Marchi S, Bucci MG, Pierelli F (1999) Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthal Vis Sci 40:2520–2527PubMed Parisi V, Manni G, Sparado M, Colacino G, Restuccia R, Marchi S, Bucci MG, Pierelli F (1999) Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthal Vis Sci 40:2520–2527PubMed
11.
go back to reference Kanamori A, Nakamura M, Escano MF, Seya R, Maeda H, Negi A (2003) Evaluation of glaucomatous damage of retinal nerve fiber layer thickness measured by optical coherence tomography. Am J Ophthalmol 135:513–520PubMedCrossRef Kanamori A, Nakamura M, Escano MF, Seya R, Maeda H, Negi A (2003) Evaluation of glaucomatous damage of retinal nerve fiber layer thickness measured by optical coherence tomography. Am J Ophthalmol 135:513–520PubMedCrossRef
12.
go back to reference Hughes AJ et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef Hughes AJ et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef
13.
go back to reference Lewis SJ, Foltynie T, Blackwell AD et al (2005) Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76:343–348PubMedCrossRef Lewis SJ, Foltynie T, Blackwell AD et al (2005) Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76:343–348PubMedCrossRef
14.
go back to reference Harnois C, Di Paolo T (1990) Decreased dopamine in the retinas of patients with Parkinson_s disease. Invest Ophthal Vis Sci 31:2473–2475PubMed Harnois C, Di Paolo T (1990) Decreased dopamine in the retinas of patients with Parkinson_s disease. Invest Ophthal Vis Sci 31:2473–2475PubMed
15.
go back to reference Onofrj M, Bodis-Wollner I (1982) Dopaminergic deficiency causes delayed VEPs in rats. Ann Neurol 11:484–490PubMedCrossRef Onofrj M, Bodis-Wollner I (1982) Dopaminergic deficiency causes delayed VEPs in rats. Ann Neurol 11:484–490PubMedCrossRef
16.
go back to reference Masson G, Mestre D, Blin O (1993) Dopaminergic modulation of visual sensitivity in man. Fundam Clin Pharmacol 7(8):449–463PubMedCrossRef Masson G, Mestre D, Blin O (1993) Dopaminergic modulation of visual sensitivity in man. Fundam Clin Pharmacol 7(8):449–463PubMedCrossRef
17.
go back to reference Nowacka B, Lubiński W, Karczewicz D (2010) Ophthalmological and electrophysiological features of Parkinson’s disease. Klin Oczna 112(7–9):247–252PubMed Nowacka B, Lubiński W, Karczewicz D (2010) Ophthalmological and electrophysiological features of Parkinson’s disease. Klin Oczna 112(7–9):247–252PubMed
Metadata
Title
Retinal nerve changes in patients with tremor dominant and akinetic rigid Parkinson’s disease
Authors
Mohammad Rohani
Arash Sefidkar Langroodi
Shadi Ghourchian
Khalil Ghasemi Falavarjani
Reza SoUdi
Gholamali Shahidi
Publication date
01-05-2013
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 5/2013
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-012-1125-7

Other articles of this Issue 5/2013

Neurological Sciences 5/2013 Go to the issue